Here's Why Globus Medical (GMED) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.
Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock?
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's What Key Metrics Tell Us About Globus Medical (GMED) Q4 Earnings
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globus Medical (GMED) Surpasses Q4 Earnings and Revenue Estimates
Globus Medical (GMED) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.84 per share a year ago.
Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript
GMED or MASI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Masimo (MASI). But which of these two stocks is more attractive to value investors?
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q4 Earnings
Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Globus Medical (GMED) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GMED vs. PEN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value investors?
